Grant: Master's Award: Canada Graduate Scholarships
University of Alberta
$17,500.00
A mobile genotyping method for tracking molecular markers of artemisinin resistant Plasmodium falciparum infections in resource-limited settings
EF 2015-16
Résumé
Over the past decade, substantial progress has been made towards the elimination of malaria. However, this progress is being threatened by the recent emergence of drug resistance to artemisinin, our most potent malaria treatment.Artemisinin resistance has been observed in the parasites that cause malaria in the South East Asia, which is the result of a mutation in the parasite's DNA. The parasites in this region are resistant to 2 out of 3 of the first-line artemisinin-based malaria treatments and are showing partial resistance to the third. Currently, no method exists to detect mutations in the parasite DNA in the field and drug resistance is determined by observing the infection over several days of treatment.I propose to develop a system that can detect mutations in the parasite before treatment is even started. This will enable more efficient treatment strategies and allow for more accurate tracking of drug resistance. Once I have optimised this method in the lab, we will obtain clinical specimens from an international collaborator to validate the system. I will then look for opportunities to test the detection system in the field. The system will also have the advantage of being able to test samples from multiple patients at the same time. This will allow researchers to more effectively track the spread of the resistance, by testing a large number of people over a short period of time.Experts estimate that if this drug resistance reaches sub-Saharan Africa, where the burden of disease is much higher than in the South East Asia, it could set malaria control back more than 25 years. The ability to accurately track drug resistance is central to its containment, and to control of malaria worldwide.
Programme
Master's Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
Alberta, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
350106
Name
Mitran Catherine
Region
Alberta
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
A mobile genotyping method for tracking molecular markers of artemisinin resistant Plasmodium falciparum infections in resource-limited settings
Programtype2
Studentship Programs
Orgnameinp2
University of Alberta
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Drug Resistance; Malaria; Nucleic Acid Detection; Point-Of-Care Diagnostics; Resource-Limited Settings
Abstract
Over the past decade, substantial progress has been made towards the elimination of malaria. However, this progress is being threatened by the recent emergence of drug resistance to artemisinin, our most potent malaria treatment.Artemisinin resistance has been observed in the parasites that cause malaria in the South East Asia, which is the result of a mutation in the parasite's DNA. The parasites in this region are resistant to 2 out of 3 of the first-line artemisinin-based malaria treatments and are showing partial resistance to the third. Currently, no method exists to detect mutations in the parasite DNA in the field and drug resistance is determined by observing the infection over several days of treatment.I propose to develop a system that can detect mutations in the parasite before treatment is even started. This will enable more efficient treatment strategies and allow for more accurate tracking of drug resistance. Once I have optimised this method in the lab, we will obtain clinical specimens from an international collaborator to validate the system. I will then look for opportunities to test the detection system in the field. The system will also have the advantage of being able to test samples from multiple patients at the same time. This will allow researchers to more effectively track the spread of the resistance, by testing a large number of people over a short period of time.Experts estimate that if this drug resistance reaches sub-Saharan Africa, where the burden of disease is much higher than in the South East Asia, it could set malaria control back more than 25 years. The ability to accurately track drug resistance is central to its containment, and to control of malaria worldwide.
Competitiondate
201512
Approvedterm2
1 yr 0 mth
Pinamesdelim
Mitran, Catherine
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~